Showing results (301-310 of 370) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Endocrinology and Metabolism|April 5, 2012
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumorsNesrin S Rechache, Yonghong Wang, Holly S Stevenson, et al.
American Journal of Human Genetics|October 18, 2016
GCM2-Activating Mutations in Familial Isolated HyperparathyroidismBin Guan, James M Welch, Julie C Sapp, et al.
Journal of the National Cancer Institute|February 27, 2018
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine TumorsNaris Nilubol, ZiQiang Yuan, Giulio F Paciotti, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Identification of Differential Transcriptional Patterns in Primary and Secondary HyperparathyroidismSamira Mercedes Sadowski, Marc Pusztaszeri, Marie-Claude Brulhart-Meynet, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 30, 2014
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemiaChunzhang Yang, Zhengping Zhuang, Stephanie M J Fliedner, et al.
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORSAmit Tirosh, J Keith Killian, Yuelin Jack Zhu, et al.
Pageof 37